** Shares of AFT Pharmaceuticals AFT.NZ fall as much as
6.9% to NZ$2.98, their biggest intraday pct fall since May 24
** Stock hits it slowest level since July 22
** The pharmaceutical firm says it expects to record an
operating loss of just under NZ$2 mln ($1.20 mln) for the six
months ended Sept. 30, compared to a profit of NZ$3.3 mln a year
ago
** Swings to operating loss, primarily due to international
and Asia sales being lower than a year earlier
** Adds the expected HY loss will likely have an impact on
co's FY forecasts too
** Stock down 14.3% YTD at 2208 GMT
(Reporting by Echha Jain in Bengaluru)
((Echha.jain@thomsonreuters.com))